title: [Pharmacological and clinical profile of Etravirine (Intelence)].
authors.forename: Michiko
authors.initials: M
authors.lastname: Iwata
authors.forename: Hideji
authors.initials: H
authors.lastname: Fujii
authors.forename: Shinya
authors.initials: S
authors.lastname: Yoshida
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Harada
mesh_terms: D019380:Anti-HIV Agents / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D003864:Depression, Chemical; D024882:Drug Resistance, Viral; D004359:Drug Therapy, Combination; D054303:HIV Reverse Transcriptase / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*; D015497:HIV-1 / Q000187:drug effects / Q000502:physiology; D006801:Humans; D009570:Nitriles; D011724:Pyridazines / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*; D011743:Pyrimidines; D016032:Randomized Controlled Trials as Topic; D014779:Virus Replication / Q000187:drug effects*
chemical_list: D019380:Anti-HIV Agents; D009570:Nitriles; D011724:Pyridazines; D011743:Pyrimidines; C451734:etravirine; C514824:reverse transcriptase, Human immunodeficiency virus 1; D054303:HIV Reverse Transcriptase